In the present study, we downloaded gene expression data of AML cohorts from The Cancer Genome Atlas (TCGA) database, identified the expression of RUNX1, TP53, and ASXL1 mutation-associated genes, and established an IPM. This evidence concerns the gene ASXL1 and acute myeloid leukemia.